12.0957.67% ( -1.005 )
Trading: Nov 16, 11:33:07 (EDT)Overview
Iambic Therapeutics (IAM)
Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles a...
- Open
- 12.690
- High
- 12.940
- Low
- 11.345
- Prev. Close
- 13.100
- Volume
- 203.46K
- Turnover
- 2.45M
- Avg Price
- 12.063
- Bid/Ask Ratio
- 80.98%
- Amplitude
- 12.18%
- 52wk High
- 25.000
- Volume Ratio
- 0.00
- Turnover Ratio
- 1.70%
- 52wk Low
- 9.600
- Float Mkt Cap
- 144.49M
- Market CapUSD
- 573.31M
- P/ETTM
- Loss
- P/EDynamic
- Loss
- P/EStatic
- --
- EPSTTM
- -1.99
- EPSDynamic
- -2.11
- EPSStatic
- --
- BVPS
- -4.91
- P/B
- --
- Circulating Supply
- 11.95M
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- 47.40M
- Min lot size
- 1
- Currency
- USD
Iambic Therapeutics Analyst Rating
View moreForecast & Rating
Nov 9, 2026Price forecast
$27.25134.81%
Forecast & RatingStrong buy
4analysts
- Strong buy75.00%
- Buy25.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 3
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong sell
- 0
News
businessinsider · Iambic Therapeutics, Inc. GAAP EPS of -$8.52 misses by $7.75, revenue of $11.4M beats by $3.11M
Market Movers · Iambic Therapeutics tumbles 8%
Quartr · IAM: Pipeline progress and $455M pro forma cash position support planned 2027 milestones
PUBT · Iambic Therapeutics Names William Rastetter Board Chairperson
Weekly Review · Weekly Recap | Iambic Therapeutics +28.81%, most brokers rate it buy
Market Movers · Iambic Therapeutics tumbles 9%
